Navigation Links
PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
Date:11/6/2008

CINCINNATI, Nov. 6 /PRNewswire/ -- PDS Biotechnology Corporation today announced that the company has been selected as a collaborator of the US National Cancer Institute's Nanotechnology Characterization Lab (NCL) to complete preclinical development of Versamune(TM)-HPV prior to filing of the Investigational New Drug Application. The NCL will perform selected physical, chemical and biological studies on behalf of the company at its facilities at the National Cancer Institute (NCI) in Frederick, Maryland. Dr. Frank Bedu-Addo, President of the Corporation stated that, "PDS Biotechnology Corporation's partnership with the NCL provides significant value to the company. The invaluable expertise of the NCL's scientists will provide the company with additional expert resources and technologies, and will facilitate rapid development of the product."

Versamune(TM)-HPV is an immunotherapy drug which has demonstrated significant promise in curing HPV infection and HPV-related cancer in preclinical animal and human model studies. Cancers caused by infection with the human papilloma virus (HPV) include cervical, head and neck and anal cancers. No cures exist for these cancers. Based on promising in vivo and in vitro efficacy data, PDS Biotechnology Corporation was awarded in August 2008, a phase I SBIR grant by the US National Institutes of Health/National Cancer Institute to develop Versamune(TM)-Melanoma to treat melanoma, which is the most aggressive form of skin cancer.

PDS Biotechnology Corporation's Versamune(TM) nanotechnology facilitates the uptake of disease-associated protein and peptide antigens by the antigen- presenting cells of the immune system and simultaneously acts a strong immune system activator (adjuvant) without the inflammatory side effects induced by current adjuvants. The result is simple, safe and cost effective nanotechnology-based drugs and vaccines that induce effective eradication of the specific cells infected with, or expressi
'/>"/>

SOURCE PDS Biotechnology Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
2. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
3. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
4. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
5. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
6. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
7. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
10. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
11. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...if., Nov. 25 Praxis Electronic Med...American Academy of Family Physicians, (AAFP) Fami...ction Survey for improving medical quality, health... for new ARRA Stimulus legislation. Praxis also ra...ositive effect in determining their salary. Finall...
(Date:11/25/2009)... Nov. 25 ERT (Nasdaq: E...y, the Company,s President and CEO, and Keith Schn...O, are scheduled to present at the 21st Annual Pip...n December 1, 2009 in New York City, New York. ,...by visiting the Company,s corporate website at ht...
(Date:11/25/2009)...., Nov. 25 Remedium Tec...am-like foam that stops severe bleeding, won first...Idea category of the Global Security Challenge 200...d from more than 100 entries from around the world...SC Security Summit conference held at the London S...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3New Fertility Financing for Donated Eggs Fills Void Left by Capital One 51716 1New Fertility Financing for Donated Eggs Fills Void Left by Capital One 51716 2Healthy Diet Exercise Keeps Mind Sharp As You Age 51712 1Healthy Diet Exercise Keeps Mind Sharp As You Age 51712 2Healthy Diet Exercise Keeps Mind Sharp As You Age 51712 3QuikByte Software Inc and Sorrento Therapeutics Inc Announce Merger Agreement 51707 1QuikByte Software Inc and Sorrento Therapeutics Inc Announce Merger Agreement 51707 2QuikByte Software Inc and Sorrento Therapeutics Inc Announce Merger Agreement 51707 3
...in bone marrow supply,leukemic cells with the amin...t when it is depleted by the cancer drug,asparagin...- The cancer drug,asparaginase fails to help cure ...LL) because molecules released by certain,cells in...g,according to investigators at St. Jude Children...
... Activity and Metabolic,Enzymes Show How Cells Res...e A, a Key Player in the Daily Biochemical Routine...7 /PRNewswire/ -- Investigators at,St. Jude Childr...,dynamic genetic and biochemical changes that make...called Coenzyme A (CoA), a key,player in metabolis...
Other Medicine Technology:Leukemic Cells Find Safe Haven in Bone Marrow 2Leukemic Cells Find Safe Haven in Bone Marrow 3Study Shows Metabolic Strategy of Stressed Cell 2Study Shows Metabolic Strategy of Stressed Cell 3
(Date:11/28/2009)... believed to affect circadian rhythm, , ...earch suggests that an internal body clock that go...nt of bipolar disorder in children. , The find...keup of 152 children with bipolar disorder, which ...and 140 children without the disorder. They linked...
(Date:11/27/2009)...v. 27 /PRNewswire/ - Uploadable USB pedometers may...wellness. A combination of advanced accelerometer ...g a long term concern over the accuracy of self-re... and reward improved participation in a fitness pr... first wellness suppliers to integrate this techno...
(Date:11/27/2009)...Nov. 27 The Gymboree Cor...bert, CFO/COO, will present at the NASDAQ OMX 23rd...air Hotel in London, England, on Wednesday, Decemb...a live broadcast of The Gymboree Corporation,s pre...gymboree.com, click on "Our Company" at the bottom...
(Date:11/27/2009)... Israel, Nov. 27 Shamir ...), a leading provider of innovative products and t... today that its board of directors had declared a ...$ 10 million (approximately NIS 37.62 million base...exchange), or approximately US$ 0.609 (approximate...
(Date:11/27/2009)...recedented medical, economic burdens, study predic...-- The number of people with diabetes in the Unite...ars, a new study predicts. , That would bring t... the disease, up from 23.7 million today. , , At...iabetes will triple, the study also warns, rising ...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
...Information Resource Center recognized Imaginis.co...n information on the Web. The recognition follows...for the same category, underscoring its influence ... information Web sites for consumers and professio...
...ure , , WESTMONT, Ill., April 7 As the economy c...e immunity to the side effects. The recent $800 b...patient records, which may help reduce the cost of...onducted by InfoSurv on behalf of EasyPay Solution...
...L) has developed the first sensor capable of measu...n of bubbles in a liquid when a high frequency sou... ensure that their instruments are properly disinf...ion. , Cavitation is used throughout the NHS by ...
...A new study presented in Clinical Cancer Research,...linical Cancer Research), shows diets high in Omeg...aenoic acid) may decrease the risk of prostate can...e cause of prostate cancer, there are several fact...
...opportunities, solutions at April 28 conference ,...center stage in the current political and economic...ing to place the patient and primary care health c...MH) model of health care delivery. , , The Patien...
...ystems, Solution to Ensure Meticulous Audit Contro... Systems, Inc., the maker of TrackWise(R) software...compliance management, today announced that Chiesi... its TrackWise Enterprise Quality Management Syst...
Other Medicine News:Health News:Medical Offices Feeling Pain of Weakened Economy 2Health News:Medical Offices Feeling Pain of Weakened Economy 3Health News:I'm forever imploding bubbles 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 3Health News:Patient-Centered Primary Care Collaborative Stakeholders Convene in Washington, DC for Working Meeting 2Health News:Patient-Centered Primary Care Collaborative Stakeholders Convene in Washington, DC for Working Meeting 3Health News:Global Therapeutics Manufacturer Selects TrackWise(R) to Reduce the Cost of Compliance 2Health News:Global Therapeutics Manufacturer Selects TrackWise(R) to Reduce the Cost of Compliance 3
Microscissors: Curved
...cs offers Q Fever IFA Test Kits for the detection ...y responses to Coxiella burnetii. Our dual antigen...titative detection and differentiation of antibodi...y providing the two phases, Focus Diagnostics' Q F...
...cs offers Q Fever IFA Test Kits for the detection ...y responses to Coxiella burnetii. Our dual antigen...titative detection and differentiation of antibodi...y providing the two phases, Focus Diagnostics' Q F...
...fluorescent antibody (IFA) test for the detection ...s to St. Louis Encephalitis virus (SLE), Western E...ephalitis virus (EEE), and California Encephalitis...l slides with fixed individual spots of SLE, WEE, ...
Medicine Products: